Plasma Level of Mitochondrial DNA in Patients With ARDS and Its Clinical Significance
NCT02883231 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2016-08-30
Summary
To observe the changes of plasma mitochondrial DNA (mtDNA) levels in patients with ARDS, and to explore its clinical significance.
Conditions
- Evaluate the Correlation Between the Level of Mitochondrial DNA in Plasma and the Prognosis of the Patients With ARDS.
Interventions
- OTHER
-
taking peripheral blood
taking peripheral blood of no more than 3ml
Sponsors & Collaborators
-
Chun Pan
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2017-03-31
- Completion
- 2017-03-31
Countries
- China
Study Locations
More Related Trials
-
Albumin Infusion in Inpatients With Decompensated Cirrhosis
NCT05719051 ·Status: UNKNOWN
-
Clinical Study of Autologous Erythrocytes Derived MPs Packaging MTX Peritoneal Perfusion to Treat Malignant Ascites
NCT03230708 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver Failure
NCT03589820 ·Status: UNKNOWN ·Phase: NA
-
Mitochondrial Function in Patients With Severe Liver Disease
NCT02457702 ·Status: TERMINATED ·Phase: NA
-
A Study of MHE in Patients With Liver Diseases
NCT04058327 ·Status: COMPLETED
-
Plasma Free Amino Acids in Patients With Hepatic Encephalopathy
NCT03306498 ·Status: UNKNOWN
-
Effect of Bacterial Translocation on Haemodynamic and Coagulation Parameters During Liver Transplantation
NCT03230214 ·Status: COMPLETED
-
Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects
NCT05249374 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Albumin and Midodrine Versus Albumin Alone in Outcome of Refractory Ascites in Patients With Decompensated Cirrhosis.
NCT04816240 ·Status: UNKNOWN ·Phase: NA
-
Injectable Collagen Scaffold™ Combined With HUC-MSCs Transplantation for Patients With Decompensated Cirrhosis
NCT02786017 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Oral Branched-chain Amino Acid Supplementation for Decompensated Cirrhotic Patients
NCT06121479 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE3
-
Prediction Value of the BreathID 13C-Methacetin Breath Test for Hepatic Decompensation
NCT02084160 ·Status: COMPLETED
-
Randomized Study of Acetylcysteine in Patients With Acute Liver Failure Not Caused by Acetaminophen
NCT00004467 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center Trial to Study Acute Liver Failure in Adults
NCT00518440 ·Status: COMPLETED
-
RESTORE Declined Livers Study
NCT04483102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver Diseases
NCT04125654 ·Status: UNKNOWN ·Phase: NA
-
Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury
NCT03204591 ·Status: UNKNOWN
-
Efficacy of Albumin Plus Midodrine v/s Albumin Alone in Reducing Incidence of Paracentesis Induced Circulatory Dysfunctions in ACLF Patients.
NCT04474262 ·Status: UNKNOWN ·Phase: NA
-
Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
NCT00511394 ·Status: SUSPENDED ·Phase: NA
-
Lung Point of Care Ultrasound to Guide Albumin Administration in Cirrhosis
NCT07072572 ·Status: COMPLETED ·Phase: PHASE3
-
Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
NCT06812390 ·Status: RECRUITING ·Phase: PHASE2
-
Transcriptional Analysis of Mechanisms in Liver Failure and Sepsis
NCT07131969 ·Status: NOT_YET_RECRUITING
-
Use of Direct Peritoneal Resuscitation in High-risk Liver Transplant Recipients
NCT05195125 ·Status: UNKNOWN ·Phase: PHASE1
-
Recombinant Human Serum Albumin in Healthy Subjects
NCT05179265 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Clinical Features of Chronic Liver Disease Complicated With Hepatopulmonary Syndrome
NCT05932927 ·Status: UNKNOWN